Litcius/Paper detail

Tocilizumab in Behçet's disease with refractory ocular and/or neurological involvement: response according to different clinical phenotypes

Belén Atienza‐Mateo, E. Beltrán, Marisa Hernández‐Garfella, Elia Valls Pascual, Lucía Martínez‐Costa, A. Atanes, C. Moriano, Miguel Cordero‐Coma, Joan M. Nolla, Carmen Carrasco Cubero, Julio Sánchez Martín, V. Calvo-Río, Rosalía Demetrio, Natalia Palmou‐Fontana, Miguel Á. González‐Gay, Ricardo Blanco

2021Clinical and Experimental Rheumatology31 citationsDOIOpen Access PDF

Abstract

Full Papers; Authors: B. Atienza-Mateo, E. Beltrán, M. Hernández-Garfella, E. Valls Pascual, L. Martínez-Costa, A. Atanes, C. Moriano, M. Cordero-Coma, J.M. Nolla, C. Carrasco Cubero, J. Sánchez Martín, V. Calvo-Río, R. Demetrio, N. Palmou-Fontana, M.Á. González-Gay, R. Blanco

Topics & Concepts

MedicineTocilizumabBehcet's diseaseRefractory (planetary science)UveitisDermatologyInternal medicineInfliximabAdalimumabRetinal vasculitisMethotrexateGastroenterologyRheumatoid arthritisVasculitisDiseaseImmunologyPhysicsAstrobiologyOcular Diseases and Behçet’s SyndromeSystemic Lupus Erythematosus ResearchIgG4-Related and Inflammatory Diseases